Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 201 | $163.69M | Healthcare | Health Services | United States | NYSE |
| 202 | $163.14M | Healthcare | Biotechnology | United States | Nasdaq |
| 203 | $162.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 204 | $160.58M | Healthcare | Medical Devices | United States | Nasdaq |
| 205 | $160.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 206 | $159.92M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 207 | $159.39M | Healthcare | Biotechnology | United States | Nasdaq |
| 208 | $158.04M | Healthcare | Healthcare Providers | United States | NYSE |
| 209 | $155.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 210 | $155.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 211 | $154.97M | Healthcare | Biotechnology | United States | Nasdaq |
| 212 | $154.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 213 | $152.63M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 214 | $149.00M | Healthcare | Healthcare Providers | United States | NYSE |
| 215 | $148.58M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 216 | $147.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 217 | $145.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 218 | $143.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 219 | $142.61M | Healthcare | Biotechnology | United States | Nasdaq |
| 220 | $141.80M | Healthcare | Healthcare Providers | United States | NYSE |
| 221 | $139.70M | Healthcare | Pharmaceuticals | United States | NYSE |
| 222 | $138.80M | Healthcare | Healthcare Providers | United States | NYSE |
| 223 | $138.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 224 | $138.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 225 | $136.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 226 | $136.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 227 | $135.84M | Healthcare | Medical Devices | United States | Nasdaq |
| 228 | $135.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 229 | $133.34M | Healthcare | Biotechnology | United States | Nasdaq |
| 230 | $130.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 231 | $129.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 232 | $127.76M | Healthcare | Medical Devices | United States | NYSE |
| 233 | $127.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 234 | $125.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 235 | $125.17M | Healthcare | Biotechnology | United States | Nasdaq |
| 236 | $125.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 237 | $124.48M | Healthcare | Biotechnology | United States | Nasdaq |
| 238 | $123.41M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 239 | $122.83M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 240 | $121.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 241 | $121.19M | Healthcare | Biotechnology | United States | Nasdaq |
| 242 | $120.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 243 | $119.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 244 | $118.66M | Healthcare | Medical Devices | United States | Nasdaq |
| 245 | $118.33M | Healthcare | Biotechnology | United States | Nasdaq |
| 246 | $117.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 247 | $117.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 248 | $117.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 249 | $117.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 250 | $116.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 251 | $116.36M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 252 | $115.98M | Healthcare | Biotechnology | United States | Nasdaq |
| 253 | $115.20M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 254 | $114.48M | Healthcare | Medical Devices | United States | NYSE |
| 255 | $113.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 256 | $112.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 257 | $111.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 258 | $110.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 259 | $110.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 260 | $110.46M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 261 | $110.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 262 | $109.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 263 | $107.86M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 264 | $107.70M | Healthcare | Healthcare Providers | United States | NYSE |
| 265 | $107.18M | Healthcare | Healthcare Providers | United States | NYSE |
| 266 | $103.81M | Healthcare | Medical Devices | United States | Nasdaq |
| 267 | $101.89M | Healthcare | Biotechnology | United States | Nasdaq |
| 268 | $101.62M | Healthcare | Medical Devices | United States | Nasdaq |
| 269 | $100.16M | Healthcare | Biotechnology | United States | Nasdaq |
| 270 | $100.05M | Healthcare | Biotechnology | United States | Nasdaq |
| 271 | $99.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 272 | $99.28M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 273 | $98.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 274 | $98.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 275 | $97.89M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 276 | $97.20M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 277 | $96.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 278 | $96.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 279 | $95.38M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 280 | $94.57M | Healthcare | Medical Devices | United States | Nasdaq |
| 281 | $93.97M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 282 | $93.70M | Healthcare | Medical Devices | United States | Nasdaq |
| 283 | $92.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 284 | $92.83M | Healthcare | Biotechnology | United States | Nasdaq |
| 285 | $92.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 286 | $90.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 287 | $89.13M | Healthcare | Pharmaceuticals | United States | NYSE |
| 288 | $87.53M | Healthcare | Medical Devices | United States | Nasdaq |
| 289 | $87.28M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 290 | $86.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 291 | $86.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 292 | $86.08M | Healthcare | Biotechnology | United States | Nasdaq |
| 293 | $85.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 294 | $82.92M | Healthcare | Biotechnology | United States | Nasdaq |
| 295 | $82.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 296 | $82.49M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 297 | $79.90M | Healthcare | Biotechnology | United States | Nasdaq |
| 298 | $79.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 299 | $79.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 300 | $79.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 686 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.